Screen LibraryAdvances in targeted cancer therapy
Saved in:
| Group Author: | |
|---|---|
| Published: |
Birkh··auser,
|
| Publisher Address: | Basel Boston |
| Publication Dates: | c2005. |
| Literature type: | Book |
| Language: | English |
| Series: |
Progress in drug research ; v. 63 |
| Subjects: | |
| Carrier Form: | vii, 303 p.: ill. ; 24 cm. |
| ISBN: |
3764371749 9783764371746 |
| Index Number: | R730 |
| CLC: | R730.53-1 |
| Call Number: | R730.53-1/A244 |
| Contents: |
Includes bibliographical references. Dawn of a new era in molecular cancer therapeutics -- Obstacles and opportunities in the clinical development of targeted therapeutics -- Tumor models for preclinical development of targeted agents -- Angiogenesis inhibitors: what is the clinical future? -- Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy -- Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development -- Targeted histone deacetylase inhibition for cancer prevention and therapy -- Inhibitors of cyclin-dependent kinase modulators for cancer therapy -- Tar |